Pulmicort Asthma Prevention (Post-PAC)

Study identifier:D5254C00004

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A study to evaluate the feasibility of a treatment algorithm in newly diagnosed asthmatic children. An open follow-up to Asthma Prevention in infants/young children (PAC)

Medical condition

asthma

Phase

N/A

Healthy volunteers

Study drug

Sex

All

Actual Enrollment

400

Study type

Interventional

Age

0 Months - 6 Years

Date

Study Start Date: 01 Jul 2001

Primary Completion Date: 01 May 2006

Study Completion Date: 01 Jun 2006

Study design

Allocation: Non-randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment

Verification:

Verified 01 Jan 2008 by AstraZeneca Pharmaceuticals

Collaborators

Inclusion and exclusion criteria

Location

Research Site

Copenhagen, Denmark

Arms	Assigned Interventions

Documents available

Trial Results Summaries
Available here

Contacts

Contact

AstraZeneca Denmark Clinical Study Information

+45 43 66 64 62

Investigators

Principal Investigator

AstraZeneca Denmark Medical Director

AstraZeneca